期刊文献+

超声分子成像的机制及研究现状 被引量:5

Mechanism and research status of ultrasound molecular imaging
下载PDF
导出
摘要 随着分子生物学的迅速发展以及疾病分子机制的逐步阐明,医学影像学已深入到细胞及分子水平。超声分子成像技术是医学分子影像学领域中重要组成部分,在当今分子影像学中占据重要地位。本文对其成像机制及研究现状进行综述。 Recently, the medical imaging has developed into the cell level, even the molecular level with the development of molecular biology and molecular mechanism of the disease. Ultrasound imaging technology is an important part of molecular imaging. Ultrasound molecular technology is a new interdiscipline derived from ultrasonic imaging technology and modern molecular biology and plays an important part in today's molecular imaging. The mechanism and research of ultrasound molecular imaging were reviewed in this article.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第4期709-711,共3页 Chinese Journal of Medical Imaging Technology
基金 国家863科技攻关项目(2006 AA02Z4F0) 国家自然科学基金重点项目(30770566)
关键词 造影剂 超声分子成像 分子影像学 Contrast media Ultrasound molecular imaging Molecular imaging
  • 相关文献

参考文献10

二级参考文献94

共引文献142

同被引文献66

  • 1王兴华,于晓玲,董宝玮.超声介导超声造影剂在分子影像与基因治疗领域中的应用[J].中华超声影像学杂志,2004,13(11):865-867. 被引量:13
  • 2许川山,王志刚.肿瘤的分子靶确认与超声纳米分子影像学[J].临床超声医学杂志,2006,8(4):233-234. 被引量:6
  • 3张勇,王志刚.纳米级超声造影剂的研究进展[J].临床超声医学杂志,2007,9(2):105-107. 被引量:9
  • 4Chen J, l.i S, Shen Q. Folic acid and cell-penetrating peptide con jugated PI.GA-PEG bifunctional nanoparticles for vincristine sul fate delivery. EurJ PharmSei, 2012,47(2) :430-443.
  • 5Macho Fernandez E, Chang J, Fontaine J, et al. Activation of in- variant Natural Killer T lymphocytes in response to the a-galacto- sylceramide analogue KRN7000 encapsulated in PLG-A-based nan- oparticles and microparticles. Int J Pharm, 2012,423(1):45-54.
  • 6Payne LS, Huang PH. The Pathobiology of collagens in glioma. Mol Cancer Res, 2013,11(10): 1129-1140.
  • 7Klibanov A L, Rychak J J, Yang W C, et al. Targeted ultra sound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging, 2006,1 (6):259-266.
  • 8Sharkey RM, Chang CH, Rossi EA, et al. Pretargeting: Taking an alternate route for localizing radionuclides. Tumour Biol, 2012,33(3) :591-600.
  • 9Liu G, Dou S, Akalin A, et al. Pretargeting vs. direct targeting of human betalox5 islet ceils subcutaneously implanted in mice using an anti-human islet cell antibody. Nucl Med Biol, 2012,39(5):645-651.
  • 10Kocbek P, Obermajer N, Cegnar M, et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoelonal antibody. J Control Release, 2007, 120(1):18-26.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部